NTRA:NASDAQ
Natera Inc
$395.66
arrow_downward
-0.53%(-2.11) 1D
$393.57
arrow_downward
-0.53% (-2.08)bedtimeAfter hours
Closed: Oct 13, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NTRA...
Open
$396.98
High
$397.53
Low
$383.01
Mkt. cap
57.03B
Avg. vol.
1.65M
Volume
1.13M
52-wk high
$437.41
52-wk low
$170.82
EPS
-$1.37
Beta
1.50
Shares outstanding
144.14M
No. of employees
6K
Open
$396.98
High
$397.53
Low
$383.01
Mkt. cap
57.03B
Avg. vol.
1.65M
Volume
1.13M
52-wk high
$437.41
52-wk low
$170.82
EPS
-$1.37
Beta
1.50
Shares outstanding
144.14M
No. of employees
6K
News stories
From web sources and news partners
ad-hoc-news.de
·
1 hour ago
Natera announces CRC trial collaboration: Natera stock after-hours at EUR 353.50
Investing.com Canada
·
11 hours ago
Natera partners with TransCode for cancer trial enrollment By Investing.com
Stock Titan
·
11 hours ago
No approved treatment exists for colorectal cancer patients with cancer signals but clear scans. A trial will test one.
ad-hoc-news.de
·
13 hours ago
Natera received FDA designation and Natera stock trades at EUR 356.60
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees6.14K
FoundedJan 1, 2004
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitenatera.com